ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0636

Chasing Pain: Investigating Somatosensory Profiles in Patients with Rheumatological Diseases Using Quantitative Sensory Testing

Claus Juergen Bauer1, Ruth Sophie Schrapper2, Simon Petzinna3, Charlotte Behning4, Tim T.A. Bender5, Peter Brossart1, Martin Muecke6 and Valentin Sebastian Schäfer1, 1Clinic of Internal Medicine III, Department of Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital of Bonn, Bonn, Germany, 2University of Bonn, Bonn, Germany, 3Clinic of Internal Medicine III, Oncology, Hematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Bonn, Germany, 4Institute of Medical Biometry, Informatics and Epidemiology, University Hospital of Bonn, Bonn, Germany, 5University Hospital of Bonn, Bonn, Germany, 6Universital Hospital of Aachen, Aachen, Germany

Meeting: ACR Convergence 2023

Keywords: pain, Psoriatic arthritis, rheumatoid arthritis, spondyloarthritis, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0609–0672) Systemic Sclerosis & Related Disorders – Clinical Poster I: Research

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pain is a prominent symptom in numerous rheumatological diseases. In order to allow for a standardized quantification and the assessment of nociceptive and non-nociceptive submodalities of various afferent nerve fiber groups and central pathways, and to identify sensitive plus or minus signs like hyperalgesia or hypesthesia, the “Quantitative Sensory Testing” (QST) protocol was developed. This tool, established by the German Neuropathic Pain Research Network (DFNS), generates somatosensory profiles [1]that can serve as a valuable tool for guiding targeted pain management strategies. This study investigates variations in somatosensory profiles between healthy individuals and patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (SpA), systemic sclerosis (SSc).

Methods: Twenty patients of each disease group (RA, PsA, SpA and SSc) and 20 healthy individuals were enrolled in this monocentric five-armed study, which received ethical approval under Institutional Review Board #065/20. Each of the 100 participants underwent the standardized QST procedure for the creation of a somatosensory profile. QST included both small fiber mediated stimuli and large fiber mediated stimuli incorporating all categories depicted in figure 1. Additional clinical data (including laboratory values, joint manifestations, and pain and disease activity assessments) was collected via standardized questionnaires (BASDAI, PASDAS, CDAI and mRSS). Data was analyzed by using linear modelling and standardized z-scores.

Results: A preliminary data analysis of all 100 study participants was performed. As shown in figure 2, all patient groups presented with increased mechanical detection thresholds (p≤0.045 for RA, PsA, SpA and SSc). Furthermore, RA, PsA and SpA patients showed diminished vibration perception (p≤0.033 for RA, PsA and SpA). A higher prevalence of allodynia was seen in all patient groups, as in 5% of patients with SSc, 15% of RA, 25% of PsA, and 15% of all SpA patients, compared with 0% in the control group.

Additionally, the study showed that people with systemic sclerosis notice cold and cold pain stimuli much earlier than healthy individuals (p=0.023).

Conclusion: Allodynia, mechanical detection and vibration are perceived through A β-fibers. Considering that all these three modalities showed deviations within the somatosensory profiles, A β-fibers seem to be most severely affected from rheumatological diseases. Accordingly, further research on the role of A β-fibers, particularly in allodynia, is thought to be supportive in the improvement of targeted and personalized pain management. Systemic sclerosis patients’ particular susceptibility to cold stimuli is explained given the presence of Raynaud’s syndrome.

Supporting image 1

Fig. 1 QST-Testing categories with their associated nerve fibers
(1) Cold detection threshold, (2) Warm detection threshold, (3) Thermal sensory limen, (4) Paradoxical heat sensations, (5) Cold pain threshold, (6) Heat pain threshold, (7) Mechanical pain threshold, (8) Mechanical pain sensitivity, (9) Wind-up-Ratio, (10) Pain pressure threshold, (11) Allodynia, (12) Vibration detection threshold, (13) Mechanical detection threshold

Supporting image 2

Fig. 2 Results of the linear modelling for Mechanical Detection Threshold (MDT) and Vibration Detection Threshold (VDT)


Disclosures: C. Bauer: None; R. Schrapper: None; S. Petzinna: None; C. Behning: None; T. Bender: None; P. Brossart: None; M. Muecke: None; V. Schäfer: None.

To cite this abstract in AMA style:

Bauer C, Schrapper R, Petzinna S, Behning C, Bender T, Brossart P, Muecke M, Schäfer V. Chasing Pain: Investigating Somatosensory Profiles in Patients with Rheumatological Diseases Using Quantitative Sensory Testing [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/chasing-pain-investigating-somatosensory-profiles-in-patients-with-rheumatological-diseases-using-quantitative-sensory-testing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chasing-pain-investigating-somatosensory-profiles-in-patients-with-rheumatological-diseases-using-quantitative-sensory-testing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology